In June, Moderna and Merck reported clinical trial follow-up results showing that their combination mRNA cancer vaccine and immunotherapy reduced the risk of melanoma recurrence in high-risk patients ...
The FDA's Pharmacy Compounding Advisory Committee met July 23-24 to consider whether 7 unapproved peptides—BPC-157, KPV, TB-500, MOTS-c, emideltide, epitalon, and semax—should be added to the agency's ...
As the number of actionable biomarkers in thoracic oncology continues to grow, the role of the multidisciplinary care team evolves to ensure patients receive comprehensive biomarker testing and ...
Dry eye is a multifactorial disease characterized by a loss of homeostasis of the tear film layer, which can present itself in different ways. Dry Eye Awareness Month is dedicated ...
Justin Balko, PharmD, PhD, explains why residual disease in triple-negative breast cancer signals a biology gap, and what ADC trials and cell-free DNA monitoring may reveal. Patients with stage 2 and ...
Dermatology offices spend ~13 hours weekly on prior authorizations, file ~39 requests per physician annually, and see roughly ...
The study assessed the impact of Control-IQ technology—an automated insulin delivery (AID) therapy—on the HEDIS-recommended target for individuals with type 2 diabetes covered by commercial insurance, ...
Cardiovascular (cMRI) identified that left bundle branch block (LBBB) does not significantly alter left atrial (LA) strain parameters in patients with ischemic or nonischemic dilated cardiomyopathy ...
Mean LDL-C at 6 months was 76.3 vs 85.6 mg/dL, yielding an adjusted difference of −6.62 mg/dL and higher attainment of LDL-C ...
Workforce expansion authorized after the 2024 Harlem outbreak remains incomplete, with 35 staff onboard versus a planned 56, ...
Subcutaneous checkpoint inhibitors drove up volume and forced staffing changes, according to Angie Maynard, PharmD, MS, and bispecifics will bring another shift. The shift toward subcutaneous ...
Urs Weber, MD, discusses why comprehensive NGS is critical and where community biomarker testing often falls short.